Simplex Trading’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,100
Closed -$2K 11641
2022
Q1
$2K Buy
2,100
+1,700
+425% +$2.77K ﹤0.01% 10000
2021
Q4
$1K Buy
+400
New +$1.57K ﹤0.01% 10327
2021
Q2
Sell
-19
Closed -$16K 10974
2021
Q1
$16K Sell
19
-37
-66% -$383 ﹤0.01% 7644
2020
Q4
$60K Sell
56
-22
-28% -$271 ﹤0.01% 5997
2020
Q3
$93K Sell
78
-5
-6% -$67 ﹤0.01% 4993
2020
Q2
$133K Sell
83
-207
-71% -$3.61K ﹤0.01% 4487
2020
Q1
$449K Buy
290
+17
+6% +$365 ﹤0.01% 2708
2019
Q4
$671K Buy
273
+241
+753% +$3.58K ﹤0.01% 2456
2019
Q3
$33K Buy
32
+29
+967% +$366 ﹤0.01% 5417
2019
Q2
$3K Sell
3
-8
-73% -$103 ﹤0.01% 6692
2019
Q1
$13K Buy
+11
New +$123 ﹤0.01% 6015
2018
Q4
Sell
-21
Closed -$22K 8113
2018
Q3
$22K Buy
21
+9
+75% +$103 ﹤0.01% 5895
2018
Q2
$16K Sell
12
-19
-61% -$296 ﹤0.01% 6060
2018
Q1
$4K Sell
31
-481
-94% -$8.12K ﹤0.01% 4882
2017
Q4
$70K Buy
+512
New +$7.44K ﹤0.01% 2125
2016
Q4
Sell
-40
Closed -$4K 6766
2016
Q3
$4K Sell
40
-4
-9% -$37 ﹤0.01% 4553
2016
Q2
$9K Buy
+44
New +$491 ﹤0.01% 3731
2016
Q1
Sell
-10
Closed -$2K 6478
2015
Q4
$2K Sell
10
-10
-50% -$148 ﹤0.01% 4647
2015
Q3
$9K Sell
20
-16
-44% -$323 ﹤0.01% 3576
2015
Q2
$9K Buy
36
+6
+20% +$115 ﹤0.01% 3191
2015
Q1
$4K Buy
30
+16
+114% +$330 ﹤0.01% 3738
2014
Q4
$3K Buy
+14
New +$327 ﹤0.01% 3573

Other funds holding EPZM

Simplex Trading's EPZM Position: Q4 2021 in Review

Simplex Trading sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 7,717 shares — an estimated $30.3K sold.

Simplex Trading first reported a position in EPZM in Q4 2014 and held it in 21 quarters. The position peaked at $350K in Q1 2020. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

  • Simplex Trading reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
  • Simplex Trading sold 7,717 Epizyme, Inc shares in Q4 2021, an estimated $30.3K.
  • Simplex Trading first reported a position in Epizyme, Inc in Q4 2014 and held it in 21 quarters.
  • Simplex Trading's Epizyme, Inc position peaked at $350K in Q1 2020.
  • 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.